These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34235979)

  • 1. Histone Deacetylase 4 Controls Extracellular Matrix Production in Orbital Fibroblasts from Graves' Ophthalmopathy Patients.
    Ekronarongchai S; Palaga T; Saonanon P; Pruksakorn V; Hirankarn N; van Hagen PM; Dik WA; Virakul S
    Thyroid; 2021 Oct; 31(10):1566-1576. PubMed ID: 34235979
    [No Abstract]   [Full Text] [Related]  

  • 2. EZH2 as a major histone methyltransferase in PDGF-BB-activated orbital fibroblast in the pathogenesis of Graves' ophthalmopathy.
    Visamol S; Palaga T; Saonanon P; Pruksakorn V; Hirankarn N; van Hagen PM; Dik WA; Virakul S
    Sci Rep; 2024 Apr; 14(1):7947. PubMed ID: 38575707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves' ophthalmopathy.
    van Steensel L; Paridaens D; Schrijver B; Dingjan GM; van Daele PL; van Hagen PM; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3091-8. PubMed ID: 19234339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic role of histone deacetylase inhibition in an
    Byeon HJ; Choi SH; Kikkawa DO; Ko J; Yoon JS
    Mol Med Rep; 2024 Dec; 30(6):. PubMed ID: 39329199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbit-infiltrating mast cells, monocytes, and macrophages produce PDGF isoforms that orchestrate orbital fibroblast activation in Graves' ophthalmopathy.
    van Steensel L; Paridaens D; van Meurs M; van Hagen PM; van den Bosch WA; Kuijpers RW; Drexhage HA; Hooijkaas H; Dik WA
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E400-8. PubMed ID: 22238384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-Derived Growth Factor-BB Enhances Adipogenesis in Orbital Fibroblasts.
    Virakul S; Dalm VA; Paridaens D; van den Bosch WA; Mulder MT; Hirankarn N; van Hagen PM; Dik WA
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5457-64. PubMed ID: 26284551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The tyrosine kinase inhibitor dasatinib effectively blocks PDGF-induced orbital fibroblast activation.
    Virakul S; Dalm VA; Paridaens D; van den Bosch WA; Hirankarn N; van Hagen PM; Dik WA
    Graefes Arch Clin Exp Ophthalmol; 2014 Jul; 252(7):1101-9. PubMed ID: 24874745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic Fibroblast Growth Factor Induces Adipogenesis in Orbital Fibroblasts: Implications for the Pathogenesis of Graves' Orbitopathy.
    Schrijver B; Kooiman MA; Kasteleijn E; van Holten-Neelen C; Virakul S; Paridaens D; Peeters RP; van Hagen PM; Dalm VASH; Dik WA
    Thyroid; 2019 Mar; 29(3):395-404. PubMed ID: 30724135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy.
    van Steensel L; Paridaens D; Dingjan GM; van Daele PL; van Hagen PM; Kuijpers RW; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1002-7. PubMed ID: 19797221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves' Ophthalmopathy.
    Virakul S; Somparn P; Pisitkun T; van der Spek PJ; Dalm VASH; Paridaens D; van Hagen PM; Hirankarn N; Palaga T; Dik WA
    Front Endocrinol (Lausanne); 2020; 11():619989. PubMed ID: 33658982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic FGF and PDGF-BB synergistically stimulate hyaluronan and IL-6 production by orbital fibroblasts.
    Virakul S; Heutz JW; Dalm VA; Peeters RP; Paridaens D; van den Bosch WA; Hirankarn N; van Hagen PM; Dik WA
    Mol Cell Endocrinol; 2016 Sep; 433():94-104. PubMed ID: 27267669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.
    van Steensel L; Hooijkaas H; Paridaens D; van den Bosch WA; Kuijpers RW; Drexhage HA; van Hagen PM; Dik WA
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E944-53. PubMed ID: 22438231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A inhibits PDGF-BB induced hyaluronan synthesis in orbital fibroblasts.
    Galgoczi E; Molnar Z; Katko M; Ujhelyi B; Steiber Z; Nagy EV
    Chem Biol Interact; 2024 Jun; 396():111045. PubMed ID: 38729283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDGF-BB Enhances the Proliferation of Cells in Human Orbital Fibroblasts by Suppressing PDCD4 Expression Via Up-Regulation of microRNA-21.
    Lee JY; Yun M; Paik JS; Lee SB; Yang SW
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):908-13. PubMed ID: 26943153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids Directly Affect Hyaluronan Production of Orbital Fibroblasts; A Potential Pleiotropic Effect in Graves' Orbitopathy.
    Galgoczi E; Katko M; Papp FR; Csiki R; Csiha S; Erdei A; Bodor M; Ujhelyi B; Steiber Z; Gyory F; Nagy EV
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The orbital fibroblast: a key player and target for therapy in graves' ophthalmopathy.
    van Steensel L; Dik WA
    Orbit; 2010 Aug; 29(4):202-6. PubMed ID: 20812837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
    Dik WA; Virakul S; van Steensel L
    Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-derived growth factor: a key factor in the pathogenesis of graves' ophthalmopathy and potential target for treatment.
    Virakul S; van Steensel L; Dalm VA; Paridaens D; van Hagen PM; Dik WA
    Eur Thyroid J; 2014 Dec; 3(4):217-26. PubMed ID: 25759797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Potential Role of Osteopontin in the Pathogenesis of Graves' Ophthalmopathy.
    Lou H; Wu LQ; Wang H; Wei RL; Cheng JW
    Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):18. PubMed ID: 34546326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.